Ligand Partner Pfizer Receives FDA Approval for DUAVEETM for the Treatment of...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Pfizer received approval today from the U.S. Food and Drug Administration (FDA) for DUAVEETM (conjugated...
View ArticleResearch and Markets: 2014 Hormone Replacement Therapy Global Strategic...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lj6j5v/hormone) has announced the addition of the "Hormone Replacement Therapy (HRT) - Global Strategic...
View ArticleGlobal Hormone Replacement Therapy (HRT) Industry
NEW YORK, March 10, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Hormone Replacement Therapy (HRT) Industry...
View ArticleNoven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important...
Download image Noven Pharmaceuticals, Inc. (PRNewsFoto/Noven Pharmaceuticals, Inc.) MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced the U.S. Patent and...
View ArticleGlobal Hormone Replacement Therapy (HRT) Industry
, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Hormone Replacement Therapy (HRT) Industry...
View ArticleAntidepressant may be hormone alternative for hot flashes
NEW YORK (Reuters Health) - A low dose of antidepressant may be almost as effective as estrogen at reducing the number of hot flashes menopausal women have to endure, according to a new study. Estrogen...
View ArticleFDA approves first nonhormonal drug for hot flashes
Published July 01, 2013The Wall Street Journal The Food and Drug Administration Friday approved the first nonhormonal drug designed to treat hot flashes, one of the most bothersome symptoms of...
View ArticleWomen have more options for relieving menopausal symptoms
More than 15 years after Viagra hit the market and former Sen. Bob Dole brought the term "erectile dysfunction" into American living rooms, hot flashes and vaginal dryness - along with the other...
View ArticleNew drug treating hot flashes without hormones
The Food & Drug Administration (FDA) approved, today, the first for moderate to severe vasomotor symptoms (VMS) for women in menopause. Noven Pharmaceuticals has received approval for the use of...
View ArticleNoven Receives FDA Approval of a New Indication with a New Dose for...
MIAMI and NEW YORK, Sept. 24, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of...
View ArticleNoven Pharmaceuticals, Inc. press release :Noven Receives FDA Approval of a...
(Source: Hisamitsu Pharmaceutical Co Ltd) Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of...
View ArticleFirst nonhormonal treatment for hot flashes, Brisdelle, approved by FDA
Women with uncomfortable hot flashes now have a medication option that doesn't involve hormones. The U.S. Food and Drug Administration approved the first nonhormonal drug to treat moderate to severe...
View ArticleNoven Announces Publication of Exploratory Analyses from Pooled Phase 3...
MIAMI and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc., today announced the publication of data on the effects of low-dose mesylate salt of paroxetine (LDMP), marketed as...
View ArticlePfizer Inc. Announces FDA Approval of DUAVEE™ (conjugated estrogens/...
(Source: Pfizer Inc) DUAVEE is the first and only therapy to pair conjugated estrogens with an estrogen agonist/antagonist, also known as a selective estrogen receptor modulator (SERM) [2] NEW...
View ArticlePfizer Inc. Announces FDA Approval of DUAVEE™ (conjugated estrogens/...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE), a leader in the development of treatments for menopausal symptoms, is pleased to announce that the United States Food and Drug Administration (FDA)...
View ArticleNoven Announces FDA Advisory Committee Vote on Investigational Low-Dose...
Tweet MIAMI, FL and NEW YORK, NY, March 4, 2013 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) Reproductive Health Drugs Advisory Committee...
View ArticleNew Minivelle® (Estradiol Transdermal System) 0.025 mg/day Dose Now Available...
The new 0.025 mg/day dosage strength for Minivelle(R) (estradiol transdermal system) is now available in the US for the prevention of postmenopausal osteoporosis. Facebook Twitter Pinterest Noven...
View ArticleNoven Announces 2007 Third Quarter Earnings Release Date
11/02/2007 04:02:01 PM EDT Business Wire Business Editors/Health/Medical Writers MIAMI--(BUSINESS WIRE)----Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced its 2007 third quarter earnings...
View ArticleBARR PHARMACEUTICALS INCQuick Quote:
BRL 56.99 (+0.66) Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Now Available in Pharmacies Nationwide 5/8/2006 --> Provides Menopausal Women A New Option In Treatment Of Vasomotor...
View ArticlePeople’s Pharmacy: Does Brisdelle work well for hot flashes?
Q: I saw a commercial for Brisdelle and wanted to know more, since I have struggled with hot flashes and night sweats for way too long. Then I learned it has the same ingredient as Paxil. I took Paxil...
View Article